Live Chat ×
Skip to main content

Vaccine-Based Prevention of Meningococcal B Disease: Tools for Interpreting and Implementing Recommendations

Please Follow These Steps to Register for the Webinar

  • Scroll down and complete the pre-test.
  • You are required to complete the pre-test in order to register for the webinar.
  • Once the pre-test is completed, click on the "Register" button on the next step and you are all set!
Overview
Meningococcal disease, specifically serotype B (MenB), is an ongoing problem in this country. The disease can develop from initial symptoms to death within 24 hours, and as many as 20% of survivors have permanent sequelae. Notably, incidence rates are often a misconception due to underdetection and under-reporting. Given how disabling this disease can be that could have been prevented with vaccination, it is essential health care workers delivering vaccinations enhance their standards of care in practice in order to deliver the highest rates of preventative care in this area. Our program will target health care providers working in the areas of pediatrics, adolescent health, college health, and immunization. The goal of the activity is to improve comprehension and initiate practice changes so as to improve immunization rates for all patients who are currently scheduled for the MenB vaccination.

Learning Objectives
At the conclusion of this activity, participants will be able to:
  • Differentiate between types of meningococcal vaccinations with respect to serotypes covered, administration schedule, impact on herd protection and tolerability.
  • Interpret Category A and B recommendations in order to better discuss meningococcal B vaccination for patients.
  • Utilizing case-based video vignettes, implement strategies to improve uptake of meningococcal B vaccine in clinical practice.
Speakers 


Stephen I. Pelton, MD
CME Course Director
Professor of Pediatrics
Boston University School of Medicine
Professor of Epidemiology
Boston University School of Public Health
Director, Section of Pediatric Infectious Diseases
Boston Medical Center


Theresa M. Fiorito, MD, MS, FAAP, CTH®
Assistant Professor
NYU Long Island
School of Medicine
Pediatric Infectious Diseases
NYU Langone
Long Island Hospital

Barbara Pahud, MD, MPH
Research Director
Pediatric Infectious Diseases
Children’s Mercy Kansas City
Associate Professor of Pediatrics
University of Missouri-Kansas City
School of Medicine Clinical Associate
Professor of Pediatrics
University of Kansas School of Medicine 

Accreditation
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Commercial Support This educational activity is supported by an independent educational grant from GlaxoSmithKline.

Conflict of Interest Policy
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Nursing Continuing Professional Development (NCPD) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all relevant conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Speakers
Dr. Fiorito has no relevant relationships to disclose.
Dr. Pahud is on the advisory board for GSK, Sanofi Pasteur, Merck and Pfizer. She has received research support from GSK and Pfizer. She is a speaker for Sanofi Pasteur and Merck.

Planning Committee
Dr. Pelton receives Grant Support from Pfizer; Merck and Cempra. He is a Consultant for Pfizer, GSK, Sanofi and Sequiris.
Dr. Marshall has received grant support from GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur and Seqirus. He is on the speakers bureau for Sanofi Pasteur.
Carole Moloney, NP is a speaker for Sanofi Pasteur.
Elizabeth Drury, Program Manager; Chris Drury, Medical Writer, have no relevant financial relationships to disclose.

Support
This program is funded by an independent educational grant from GlaxoSmithKline.

Accreditation
ACCME Accreditation
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


AAP Accreditation
This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.